1. Home
  2. UUU vs NCNA Comparison

UUU vs NCNA Comparison

Compare UUU & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UUU
  • NCNA
  • Stock Information
  • Founded
  • UUU 1969
  • NCNA 1997
  • Country
  • UUU United States
  • NCNA United Kingdom
  • Employees
  • UUU N/A
  • NCNA N/A
  • Industry
  • UUU Electronic Components
  • NCNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UUU Technology
  • NCNA Health Care
  • Exchange
  • UUU Nasdaq
  • NCNA Nasdaq
  • Market Cap
  • UUU 8.3M
  • NCNA 6.6M
  • IPO Year
  • UUU N/A
  • NCNA 2017
  • Fundamental
  • Price
  • UUU $6.27
  • NCNA $4.07
  • Analyst Decision
  • UUU
  • NCNA
  • Analyst Count
  • UUU 0
  • NCNA 0
  • Target Price
  • UUU N/A
  • NCNA N/A
  • AVG Volume (30 Days)
  • UUU 3.7M
  • NCNA 442.3K
  • Earning Date
  • UUU 08-19-2025
  • NCNA 08-20-2025
  • Dividend Yield
  • UUU 15.38%
  • NCNA N/A
  • EPS Growth
  • UUU N/A
  • NCNA N/A
  • EPS
  • UUU 1.19
  • NCNA N/A
  • Revenue
  • UUU $22,789,285.00
  • NCNA N/A
  • Revenue This Year
  • UUU N/A
  • NCNA N/A
  • Revenue Next Year
  • UUU N/A
  • NCNA N/A
  • P/E Ratio
  • UUU $5.33
  • NCNA N/A
  • Revenue Growth
  • UUU 30.84
  • NCNA N/A
  • 52 Week Low
  • UUU $1.11
  • NCNA $2.78
  • 52 Week High
  • UUU $8.27
  • NCNA $1,650.00
  • Technical
  • Relative Strength Index (RSI)
  • UUU 62.11
  • NCNA 44.33
  • Support Level
  • UUU $4.78
  • NCNA $2.82
  • Resistance Level
  • UUU $6.82
  • NCNA $4.88
  • Average True Range (ATR)
  • UUU 0.92
  • NCNA 0.31
  • MACD
  • UUU 0.06
  • NCNA 0.47
  • Stochastic Oscillator
  • UUU 63.99
  • NCNA 61.43

About UUU Universal Security Instruments Inc.

Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Share on Social Networks: